Eqis Capital Management, Inc. Adma Biologics, Inc. Transaction History
Eqis Capital Management, Inc.
- $1.19 Billion
- Q2 2025
A detailed history of Eqis Capital Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 13,107 shares of ADMA stock, worth $191,624. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,107
Previous 15,279
14.22%
Holding current value
$191,624
Previous $303,000
21.45%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$273 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$177 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.4 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...